MICHAEL BRAUN to Follow-Up Studies
This is a "connection" page, showing publications MICHAEL BRAUN has written about Follow-Up Studies.
Connection Strength
0.130
-
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study. Clin Colorectal Cancer. 2026 03; 25(1):115-124.
Score: 0.030
-
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM. Curr Oncol. 2024 12 11; 31(12):7903-7913.
Score: 0.029
-
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. J Clin Oncol. 2021 11 20; 39(33):3705-3715.
Score: 0.023
-
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation. Clin Cancer Res. 2021 02 15; 27(4):1119-1130.
Score: 0.022
-
Therapeutic Plasma Exchange Use in Pediatric Neurologic Disorders at a Tertiary Care Center: A 10-Year Review. J Child Neurol. 2018 02; 33(2):140-145.
Score: 0.018
-
Cryptococcosis associated with crescentic glomerulonephritis. Pediatr Nephrol. 2008 May; 23(5):827-30.
Score: 0.009